Table 1.
Clinical Features of COVID-19, SARS, and MERS
| Symptom | COVID-19 |
SARS |
MERS |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Studya |
|||||||||
| 1 (n = 62) [91] |
2 (n = 1099) [8] |
3 (n = 138) [92] |
4 (n = 140) [9] |
5 (n = 41) [7] |
6 (n = 99) [10] |
Range (average) | 7 Range [93] |
8 Range [94] |
|
| Fever | 77.4 | 88.7 | 98.6 | 91.7 | 97.6 | 82.8 | 77.4–98.6 (89.5) | 99–100 | 98 |
| Cough | 80.6 | 67.8 | 59.4 | 75.0 | 75.6 | 81.8 | 67.8–86.2 (73.4) | 62–100 | 83 |
| Dyspnea | – | – | 31.2 | 36.7 | 55.0 | 31.3 | 31.2–55.0 (38.5) | – | – |
| Myalgia | 51.6 | 14.9 | 34.8 | – | 43.9 | 11.1 | 11.1–51.6 (31.3) | 45–61 | 32 |
| Panting | 3.2 | – | – | – | 29.3 | – | 3.2–29.3 (16.2) | – | – |
| Headache | 34.4 | 13.6 | 6.5 | – | 7.9 | 8.1 | 6.5–34.4 (14.1) | 20–56 | 11 |
| Sore throat | – | 13.9 | 17.4 | – | – | 5.1 | 5.1–17.4 (12.1) | 13–25 | 14 |
| Nausea/vomiting | – | 5.0 | 6.3-10 | 22.3 | – | 1.0 | 2.0–22.3 (9.4) | 20–35 | 21 |
| Diarrhea | 4.8 | 3.8 | 10.1 | 12.9 | 2.6 | 2.0 | 2.0–12.9 (6.1) | 20–25 | 26 |
| Rhinorrhea | – | – | – | – | – | 4.0 | 4.0 (4.0) | 2–24 | 6 |
| Abdominal pain | – | – | 2.2 | 5.8 | – | – | 2.2–5.8 (4.0) | – | – |
a
Percentage of study subjects that experienced the indicated symptom; for fields without values, this symptom was not evaluated.